Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
about
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency.Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia.Eltrombopag in immune thrombocytopenia: efficacy review and update on drug safety.
P2860
Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
@ast
Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
@en
type
label
Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
@ast
Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
@en
prefLabel
Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
@ast
Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
@en
P2093
P2860
P1476
Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.
@en
P2093
Ayush Shukla
Deependra Kumar Yadav
Sanjay Mishra
Yogendra Singh Yadav
P2860
P2888
P304
P356
10.1007/S12185-014-1533-Y
P577
2014-02-14T00:00:00Z
P6179
1032471527